94 related articles for article (PubMed ID: 12297456)
21. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
22. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
24. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional conformal radiation therapy and periodic irradiation with the deep insipration breath-hold technique for hepatocellular carcinoma.
Pattaranutaporn P; Chansilpa Y; Ieumwananonthachai N; Kakanaporn C; Onnomdee K; Mungkung N; Santisiri R
J Med Assoc Thai; 2001 Dec; 84(12):1692-700. PubMed ID: 11999815
[TBL] [Abstract][Full Text] [Related]
26. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
[TBL] [Abstract][Full Text] [Related]
27. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
[TBL] [Abstract][Full Text] [Related]
28. Impact of different CT slice thickness on clinical target volume for 3D conformal radiation therapy.
Prabhakar R; Ganesh T; Rath GK; Julka PK; Sridhar PS; Joshi RC; Thulkar S
Med Dosim; 2009; 34(1):36-41. PubMed ID: 19181254
[TBL] [Abstract][Full Text] [Related]
29. [Value of conformal radio therapy for middle stage or advanced primary hepatocellular carcinoma].
Chen LH; Guan J
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):55-7. PubMed ID: 12527518
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
Igaki H; Nakagawa K; Shiraishi K; Shiina S; Kokudo N; Terahara A; Yamashita H; Sasano N; Omata M; Ohtomo K
Jpn J Clin Oncol; 2008 Jun; 38(6):438-44. PubMed ID: 18495749
[TBL] [Abstract][Full Text] [Related]
33. Treatment of primary liver cancer using highly-conformal radiotherapy with kV-image guidance and respiratory control.
Law AL; Ng WT; Lee MC; Chan AT; Fung KH; Li F; Lao WC; Lee AW
Radiother Oncol; 2012 Jan; 102(1):56-61. PubMed ID: 21640423
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of high-dose three-dimensional conformal radiotherapy and conventional radiotherapy for non-small-cell lung cancer.
Xu SJ; Shi YS; Song HC; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):937-8. PubMed ID: 12377626
[TBL] [Abstract][Full Text] [Related]
35. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
36. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
[TBL] [Abstract][Full Text] [Related]
38. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effects of three-dimensional conformal radiation therapy for locally recurrent nasopharyngeal carcinoma].
Wu DH; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1028-9. PubMed ID: 12433640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
